Description:[001] The present invention relates to the field of medical imaging and artificial intelligence, specifically focusing on the automated detection, classification, and severity assessment of brain tumors using advanced machine learning and deep learning techniques. More particularly, the invention integrates superpixel-based image segmentation with a Transferable Ensemble Learning Deep Convolutional Neural Network (TEL-DCNN) for feature extraction and classification, along with a Bayesian Probability Layer enhanced with Fuzzy Logic (BPL-Fuzzy) for precise severity evaluation. This invention aims to enhance diagnostic accuracy, reduce manual intervention, and provide a robust system for real-time tumor assessment in clinical settings.
BACKGROUND OF THE INVENTION
[002] Brain tumors are among the most critical and life-threatening conditions affecting the central nervous system. The early detection and accurate classification of brain tumors play a vital role in determining the appropriate treatment and improving patient survival rates. Medical imaging techniques, particularly Magnetic Resonance Imaging (MRI), are widely used for brain tumor diagnosis due to their non-invasive nature and ability to provide high-resolution images of brain tissue. However, analyzing MRI scans manually is time-consuming, highly dependent on radiologists' expertise, and prone to human error, leading to potential misdiagnoses or delayed treatment.
[003] Traditional methods for brain tumor detection involve manual segmentation and classification by medical professionals, which require significant effort and expertise. The accuracy of these methods can be affected by image artifacts, low contrast, and variations in tumor shape, size, and location. In addition, different types of brain tumors, such as gliomas, meningiomas, and pituitary tumors, exhibit complex morphological characteristics that further complicate the classification process. Conventional machine learning techniques have been introduced to automate tumor detection, but their performance is often limited due to challenges in feature extraction and model generalization.
[004] Recent advancements in deep learning, particularly Convolutional Neural Networks (CNNs), have revolutionized medical image analysis by providing state-of-the-art performance in feature extraction and classification tasks. CNNs can learn complex hierarchical features directly from raw image data, eliminating the need for handcrafted feature engineering. However, standard CNN models often struggle with overfitting, require large annotated datasets, and may not effectively capture spatial relationships in medical images, especially when dealing with complex tumor structures.
[005] To address these challenges, superpixel-based segmentation techniques have been introduced to enhance image preprocessing. Superpixel algorithms divide an image into homogeneous regions, preserving important structural details while reducing computational complexity. By incorporating superpixel-based segmentation, tumor regions can be accurately isolated, improving the overall performance of deep learning models. This approach significantly enhances tumor boundary detection and ensures that only relevant features are extracted for classification.
[006] Despite the success of deep learning models, a major limitation remains in handling uncertainty in medical diagnoses. Brain tumor classification often involves cases where the tumor characteristics are ambiguous, making it difficult to assign a definitive category. Traditional CNN-based models typically provide deterministic outputs without considering the inherent uncertainty in medical imaging. This limitation can lead to misclassifications, particularly in borderline cases where tumors exhibit mixed characteristics of benign and malignant forms.
[007] To overcome these limitations, probabilistic models such as Bayesian inference and fuzzy logic have been integrated into deep learning frameworks. Bayesian Probability Layers (BPL) allow deep learning models to estimate uncertainty by incorporating probabilistic reasoning into classification tasks. Fuzzy logic, on the other hand, enables the system to handle imprecise and ambiguous inputs by modeling uncertainties in medical decision-making. The combination of Bayesian inference and fuzzy logic provides a more reliable and interpretable classification system, improving diagnostic confidence and accuracy.
[008] The present invention introduces a novel hybrid approach that integrates Superpixel-based segmentation, Transferable Ensemble Learning with Deep Convolutional Neural Networks (TEL-DCNN), and a Bayesian Probability Layer enhanced with Fuzzy Logic (BPL-Fuzzy). The TEL-DCNN model is designed to leverage knowledge from multiple pre-trained deep learning models, enabling effective feature extraction and robust classification. The BPL-Fuzzy framework refines the classification process by incorporating uncertainty estimation and domain-specific fuzzy rules, leading to improved severity assessment of brain tumors.
[009] The proposed system begins with an advanced image preprocessing module, where MRI scans undergo noise reduction, contrast enhancement, and normalization to improve image quality. Superpixel-based segmentation is then applied to extract precise tumor regions while preserving crucial morphological features. The TEL-DCNN model is responsible for learning high-level representations from segmented tumor regions and performing initial classification into benign, malignant, or uncertain categories. The final stage of the system utilizes the BPL-Fuzzy logic layer to assess tumor severity by analyzing probabilistic outputs and incorporating medical domain knowledge into the decision-making process.
[010] One of the key advantages of this invention is its ability to handle complex and uncertain cases more effectively than traditional CNN-based methods. The TEL-DCNN model ensures robustness by leveraging ensemble learning techniques, while the BPL-Fuzzy framework enhances decision reliability. Additionally, the system is designed for real-time analysis, making it suitable for clinical applications where rapid and accurate tumor assessment is crucial for treatment planning.
[011] Furthermore, the proposed system offers a user-friendly interface for visualizing classification results and severity assessments. This interface can be integrated into existing hospital imaging systems, allowing radiologists and medical professionals to access AI-assisted diagnostic reports easily. The system's ability to provide interpretable and probabilistic outputs makes it a valuable tool in clinical decision-making, reducing dependency on subjective assessments and enhancing overall diagnostic efficiency.
[012] In summary, this invention addresses the key challenges in automated brain tumor classification and severity assessment by introducing a novel hybrid approach that combines Superpixel-based segmentation, TEL-DCNN, and BPL-Fuzzy logic. By leveraging these advanced techniques, the proposed system improves segmentation accuracy, enhances classification robustness, and provides a reliable framework for uncertainty estimation in medical diagnosis. This innovation represents a significant step forward in AI-driven healthcare, offering a powerful tool for early brain tumor detection and personalized treatment planning.
SUMMARY OF THE INVENTION
[013] The present invention introduces an advanced automated system for brain tumor categorization and severity identification using a novel combination of Superpixel-based segmentation, Transferable Ensemble Learning with Deep Convolutional Neural Networks (TEL-DCNN), and a Bayesian Probability Layer enhanced with Fuzzy Logic (BPL-Fuzzy). This invention aims to overcome the limitations of traditional tumor detection methods by providing a highly accurate, interpretable, and robust AI-driven diagnostic tool for medical imaging applications.
[014] The system begins with an image preprocessing module that enhances MRI scan quality through noise reduction, contrast enhancement, and normalization. This ensures that critical tumor features are preserved while minimizing distortions. Superpixel-based segmentation is then applied to partition the image into homogeneous regions, allowing precise extraction of tumor boundaries and reducing computational complexity. This segmentation step significantly improves feature extraction and ensures that only relevant tumor regions are analyzed, reducing false positives and misclassifications.
[015] For tumor classification, the invention utilizes the TEL-DCNN framework, which integrates multiple pre-trained deep learning models to enhance learning efficiency and generalization capabilities. This ensemble approach allows the system to leverage features from different architectures, ensuring improved accuracy and robustness in tumor classification. The TEL-DCNN model classifies tumors into different categories, including benign, malignant, and uncertain cases, based on the extracted deep features.
[016] To address uncertainty in tumor classification, the invention incorporates a Bayesian Probability Layer (BPL) enhanced with Fuzzy Logic. The BPL framework introduces probabilistic reasoning, allowing the system to quantify uncertainty in predictions. This is particularly useful in ambiguous cases where tumors exhibit characteristics of both benign and malignant forms. Fuzzy Logic further refines the classification by incorporating domain-specific rules, mimicking the decision-making process of expert radiologists. By combining these techniques, the system provides a more reliable and interpretable severity assessment.
[017] The severity assessment module analyzes probabilistic outputs from the BPL-Fuzzy framework to determine the aggressiveness of the tumor. This information is crucial for clinicians to prioritize treatment plans based on the severity level. The system is designed to generate user-friendly reports with visualizations of tumor segmentation, classification probabilities, and severity scores, assisting medical professionals in making informed decisions.
[018] A key advantage of this invention is its ability to function in real-time clinical environments, providing fast and accurate tumor classification without requiring extensive manual intervention. The hybrid approach of TEL-DCNN and BPL-Fuzzy logic enhances the system's adaptability to various MRI datasets and ensures high diagnostic reliability. Furthermore, the invention is designed for seamless integration with existing hospital imaging systems, allowing radiologists to utilize AI-assisted diagnostics efficiently.
[019] In summary, this invention presents a novel AI-based framework for brain tumor detection, classification, and severity assessment. By leveraging Superpixel-based segmentation, TEL-DCNN, and BPL-Fuzzy logic, the system enhances diagnostic accuracy, improves robustness, and provides an interpretable decision-making framework. This advancement in AI-driven medical imaging has the potential to significantly improve early brain tumor detection, assisting radiologists in delivering timely and precise diagnoses.
BRIEF DESCRIPTION OF THE DRAWINGS
[020] The accompanying figures included herein, and which form parts of the present invention, illustrate embodiments of the present invention, and work together with the present invention to illustrate the principles of the invention Figures:
[021] Figure 1, illustrates the overall architecture of the proposed brain tumor categorization and severity identification system.
[022] Figure 2, illustrates a detailed visualization of the Superpixel-based segmentation process.
DETAILED DESCRIPTION OF THE INVENTION
[023] The present invention provides an advanced artificial intelligence-based system for automated brain tumor categorization and severity identification, integrating Superpixel-based segmentation, Transferable Ensemble Learning with Deep Convolutional Neural Networks (TEL-DCNN), and a Bayesian Probability Layer enhanced with Fuzzy Logic (BPL-Fuzzy). The invention aims to enhance the accuracy, reliability, and interpretability of brain tumor classification by overcoming the limitations of conventional deep learning methods.
[024] Image Preprocessing and Enhancement
The first stage of the proposed system involves preprocessing MRI scans to enhance image quality and improve feature extraction. Raw MRI images often suffer from noise, low contrast, and variations in brightness, which can affect segmentation and classification accuracy. The preprocessing module applies techniques such as Gaussian filtering for noise reduction, histogram equalization for contrast enhancement, and intensity normalization to standardize pixel intensity values across different scans. This step ensures that all images are in a consistent format before further processing.
[025] Superpixel-Based Tumor Segmentation
Following preprocessing, the system applies a Superpixel-based segmentation algorithm to divide the MRI image into small, meaningful regions that preserve important structural details. Unlike traditional pixel-wise segmentation, which can be computationally intensive and prone to boundary errors, Superpixel segmentation groups pixels with similar properties, enabling precise tumor region extraction. This segmentation technique enhances the ability of deep learning models to focus on relevant tumor features while reducing computational complexity. The segmented tumor region is then passed to the feature extraction module.
[026] Feature Extraction Using TEL-DCNN
The Transferable Ensemble Learning with Deep Convolutional Neural Networks (TEL-DCNN) is a key component of the invention, designed to leverage the strengths of multiple pre-trained deep learning models. Instead of relying on a single CNN architecture, the TEL-DCNN framework combines features from multiple models such as ResNet, VGG, Inception, and DenseNet, creating a robust ensemble that enhances classification accuracy. The ensemble learning approach ensures that the system generalizes well across different MRI datasets, reducing the risk of overfitting and improving performance on unseen cases.
During feature extraction, the TEL-DCNN model processes the segmented tumor region and extracts hierarchical features such as texture, shape, and intensity variations. These features are then passed through fully connected layers for classification. The TEL-DCNN framework is designed to categorize brain tumors into three primary types: glioma, meningioma, and pituitary tumors, based on their learned representations. Additionally, a fourth category—uncertain cases—is introduced to handle ambiguous tumor patterns that require further analysis.
[027] Classification and Uncertainty Estimation Using BPL-Fuzzy
To improve classification reliability and handle uncertainty in medical imaging, the invention integrates a Bayesian Probability Layer (BPL) with Fuzzy Logic (BPL-Fuzzy). Traditional CNN-based classifiers provide deterministic outputs, which may not be suitable for cases with high variability or mixed tumor characteristics. The BPL framework introduces probabilistic reasoning, enabling the model to assign confidence scores to its predictions. This approach helps distinguish between high-certainty and low-certainty classifications, ensuring that uncertain cases are flagged for further medical review.
The Fuzzy Logic component enhances classification by incorporating expert knowledge and linguistic rules into the decision-making process. Fuzzy logic allows the system to handle ambiguous cases by modeling uncertainty using membership functions. For instance, if a tumor exhibits characteristics of both benign and malignant types, the fuzzy inference system assigns a probability distribution rather than forcing a binary classification. This feature improves diagnostic reliability and reduces false positives or negatives in tumor detection.
[028] Severity Identification and Risk Assessment
Beyond classification, the invention includes a severity identification module that evaluates the aggressiveness of a detected tumor. This module analyzes multiple parameters, including tumor size, shape irregularity, intensity variations, and patient-specific factors. The BPL-Fuzzy system processes these inputs and assigns a severity score, categorizing tumors as low-risk, moderate-risk, or high-risk. The severity assessment helps clinicians determine the urgency of treatment and select appropriate intervention strategies.
[029] Real-Time Clinical Deployment and User Interface
The invention is designed for real-time deployment in clinical environments, offering an intuitive graphical user interface (GUI) for radiologists and medical practitioners. The GUI provides:
• Visualization of segmented tumor regions with highlighted boundaries.
• Classification results with confidence scores from the TEL-DCNN model.
• Severity assessment reports, assisting doctors in treatment planning.
• Uncertainty alerts for cases that require further examination.
The system can be integrated into hospital imaging infrastructure, allowing seamless access to MRI scan analysis and AI-assisted diagnostics. It also supports cloud-based processing for remote analysis, enabling second opinions from expert radiologists.
[030] Advantages of the Proposed System
The present invention offers several key advantages over existing tumor classification techniques:
• Higher accuracy through the ensemble learning approach of TEL-DCNN.
• Improved segmentation precision using Superpixel-based techniques.
• Reliable classification with Bayesian inference for uncertainty estimation.
• Interpretability through Fuzzy Logic-based decision-making.
• Real-time usability in clinical settings, reducing diagnosis time.
• Scalability for integration with hospital systems and cloud-based platforms.
[031] Experimental Validation and Performance Metrics
To evaluate the effectiveness of the proposed system, extensive testing is performed using publicly available MRI datasets, such as BraTS (Brain Tumor Segmentation Challenge) and other clinical datasets. Performance metrics, including accuracy, precision, recall, F1-score, and AUC-ROC, are analyzed to compare the invention against existing deep learning-based classification methods. The results demonstrate superior performance in terms of segmentation accuracy, classification reliability, and uncertainty handling, validating the effectiveness of the TEL-DCNN and BPL-Fuzzy framework.
[032] The present invention introduces a novel AI-driven system for brain tumor categorization and severity identification by integrating Superpixel-based segmentation, Transferable Ensemble Learning with Deep Convolutional Neural Networks (TEL-DCNN), and Bayesian Probability Layer enhanced with Fuzzy Logic (BPL-Fuzzy). By addressing the limitations of conventional deep learning models, the proposed system improves classification accuracy, enhances segmentation precision, and provides an interpretable decision-making framework. The introduction of an uncertainty-aware Bayesian approach and Fuzzy Logic ensures reliable classification, reducing false diagnoses and assisting medical professionals in making informed decisions. Additionally, the system's severity identification module enables better risk assessment, facilitating timely intervention and personalized treatment strategies.
[033] Looking ahead, the future scope of this invention extends to various enhancements and broader applications. The system can be expanded to include multi-modal imaging data, such as CT and PET scans, to improve diagnostic accuracy further. The integration of explainable AI (XAI) techniques can enhance model transparency, enabling better interpretability of results for clinical practitioners. Moreover, real-time cloud-based deployment can facilitate remote diagnosis and second-opinion consultations, benefiting healthcare facilities with limited radiological expertise. The system can also be adapted for other neurological disorders, including Alzheimer’s and stroke detection, broadening its impact in medical imaging and AI-assisted diagnostics.
[034] In conclusion, this invention represents a significant advancement in AI-driven medical imaging, providing a highly accurate, interpretable, and scalable solution for brain tumor diagnosis. By leveraging cutting-edge machine learning and uncertainty estimation techniques, the system offers a promising pathway toward improved patient outcomes, early detection, and enhanced clinical decision support. With continuous research and advancements, this technology has the potential to revolutionize the field of neuro-oncology and pave the way for future AI-powered diagnostic tools in healthcare.
, Claims:1. A computer-implemented system for brain tumor categorization and severity identification, comprising Superpixel-based segmentation, Transferable Ensemble Learning with Deep Convolutional Neural Networks (TEL-DCNN), and a Bayesian Probability Layer enhanced with Fuzzy Logic (BPL-Fuzzy), wherein the system processes MRI scans to classify brain tumors and determine their severity.
2. The system of claim 1, wherein the Superpixel-based segmentation algorithm divides an input MRI scan into homogeneous regions, preserving structural integrity and improving tumor boundary detection for enhanced feature extraction.
3. The system of claim 1, wherein the TEL-DCNN framework combines multiple pre-trained deep learning models, including ResNet, VGG, Inception, and DenseNet, to extract hierarchical tumor features and improve classification accuracy.
4. The system of claim 1, wherein the Bayesian Probability Layer estimates classification confidence by providing probabilistic outputs, thereby enabling uncertainty-aware decision-making for improved diagnostic reliability.
5. The system of claim 1, wherein the Fuzzy Logic module incorporates linguistic rules and expert knowledge to handle ambiguous tumor characteristics and refine the final classification outcome.
6. The system of claim 1, wherein the classification module categorizes brain tumors into glioma, meningioma, and pituitary tumor types based on extracted deep learning features and probabilistic inference.
7. The system of claim 1, wherein the severity identification module evaluates tumor risk levels by analyzing shape irregularity, intensity variations, and patient-specific factors, assigning a severity score to assist in clinical decision-making.
8. The system of claim 1, wherein the graphical user interface (GUI) provides real-time visualization of segmented tumor regions, classification results with confidence scores, and severity assessment to assist radiologists in making informed diagnoses.
9. The system of claim 1, wherein the classification and severity identification system is deployed on a cloud-based platform to enable remote access, real-time processing, and second-opinion consultation for enhanced medical decision support.
10. A method for automated brain tumor classification and severity identification, comprising steps of image preprocessing, Superpixel-based segmentation, feature extraction using TEL-DCNN, classification with Bayesian Probability Layer, severity assessment with Fuzzy Logic, and result visualization, wherein the method ensures high diagnostic accuracy, interpretability, and uncertainty-aware decision-making in clinical applications.